CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)

NCT02056808 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy

NCT03508947 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy

NCT03039686 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Evaluating MYO-029 in Adult Muscular Dystrophy

NCT00104078 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD

NCT02515669 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects

NCT01128855 ·Status: COMPLETED ·Phase: PHASE1

Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

NCT02740972 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy

NCT03400852 ·Status: TERMINATED ·Phase: PHASE2

Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy

NCT01451281 ·Status: COMPLETED

A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy

NCT06280209 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)

NCT06114056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.

NCT07058662 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Extension Study of Drisapersen in DMD Subjects

NCT02636686 ·Status: NO_LONGER_AVAILABLE

Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy

NCT03907072 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

NCT01099761 ·Status: TERMINATED ·Phase: PHASE2

Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy

NCT05753462 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)

NCT04184882 ·Status: TERMINATED ·Phase: PHASE1

A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration

NCT01910649 ·Status: TERMINATED ·Phase: PHASE2

A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)

NCT01957059 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

NCT07188012 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy

NCT05938023 ·Status: TERMINATED ·Phase: PHASE2

Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients

NCT02196467 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

NS-050/NCNP-03 in Boys With DMD (Meteor50)

NCT06053814 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

NCT05996003 ·Status: RECRUITING ·Phase: PHASE2

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

NCT04768062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3